RESEARCH FUNDING

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

Share

The Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) funding program from the National Institutes of Health (NIH) supports the development of innovative, enabling tools and technologies in the areas of kidney, urologic, and hematologic diseases. Applications are open to researchers in the USA and worldwide. Applicants may apply for up to 275,000 USD for over 2 years. Opportunity ID: PAR-23-119. Full applications are due June 16, 2023.
Logo3

Be the first to know

Sign-up for Personalized Grant alerts

Sign-up for the
scientifyRESEARCH
monthly research
funding newsletter

You can unsubscribe at any time.